Table 4 Distribution of LR-HPV genotypes in study participants
HPV type | Single infection | Double infections | Multiple infections | Total infections | |||
|---|---|---|---|---|---|---|---|
Positive no | % (95% CI) | Positive no | % (95% CI) | Positive no | % (95% CI) | % (95% CI) | |
HPV6 | 78 | 0.5 (0.4–0.6) | 88 | 0.6 (0.4–0.7) | 52 | 0.3 (0.2–0.4) | 1.4 (1.2–1.6) |
HPV61 | 111 | 0.7 (0.6–0.8) | 27 | 0.2 (0.1–0.2) | 30 | 0.2 (0.1–0.3) | 1.1 (0.9–1.2) |
HPV81 | 70 | 0.4 (0.3–0.6) | 55 | 0.4 (0.3–0.4) | 43 | 0.3 (0.2–0.4) | 1.1 (0.9–1.2) |
HPV54 | 79 | 0.5 (0.4–0.6) | 51 | 0.3 (0.2–0.4) | 32 | 0.2 (0.1–0.3) | 1.0 (0.9–1.2) |
HPV11 | 49 | 0.3 (0.2–0.4) | 35 | 0.2 (0.1–0.3) | 32 | 0.2 (0.1–0.3) | 0.7 (0.6–0.9) |
HPV40 | 48 | 0.3 (0.2–0.4) | 23 | 0.1 (0.1–0.2) | 9 | 0.1 (0.0–0.1) | 0.5 (0.4–0.6) |
HPV84 | 27 | 0.2 (0.1–0.2) | 26 | 0.2 (0.1–0.2) | 25 | 0.2 (0.1–0.2) | 0.5 (0.4–0.6) |
HPV34 | 27 | 0.2 (0.1–0.2) | 14 | 0.1 (0.0–0.1) | 15 | 0.1 (0.0–0.1) | 0.4 (0.3–0.5) |
HPV70 | 16 | 0.1 (0.1–0.2) | 16 | 0.1 (0.1–0.2) | 10 | 0.1 (0.0–0.1) | 0.3 (0.2–0.4) |
HPV44 | 20 | 0.1 (0.1–0.2) | 12 | 0.1 (0.0–0.1) | 9 | 0.1 (0.0–0.1) | 0.3 (0.2–0.3) |
HPV42 | 21 | 0.1 (0.1–0.2) | 9 | 0.1 (0.0–0.1) | 8 | 0.1 (0.0–0.1) | 0.2 (0.2–0.3) |
HPV55 | 10 | 0.1 (0.0–0.1) | 16 | 0.1 (0.1–0.2) | 3 | 0.0 (0.0–0.0) | 0.2 (0.1–0.3) |
HPV73 | 12 | 0.1 (0.0–0.1) | 5 | 0.0 (0.0–0.1) | 11 | 0.1 (0.0–0.1) | 0.2 (0.1–0.2) |
HPV43 | 4 | 0.0 (0.0–0.1) | 8 | 0.1 (0.0–0.1) | 9 | 0.1 (0.0–0.1) | 0.1 (0.1–0.2) |
HPV69 | 8 | 0.1 (0.0–0.1) | 6 | 0.0 (0.0–0.1) | 4 | 0.0 (0.0–0.1) | 0.1 (0.1–0.2) |
HPV57 | 4 | 0.0 (0.0–0.1) | 9 | 0.1 (0.0–0.1) | 0 | 0.0 (0.0–0.0) | 0.1 (0.0–0.1) |
HPV83 | 5 | 0.0 (0.0–0.1) | 3 | 0.0 (0.0–0.0) | 3 | 0.0 (0.0–0.0) | 0.1 (0.0–0.1) |
HPV67 | 3 | 0.0 (0.0–0.0) | 1 | 0.0 (0.0–0.0) | 4 | 0.0 (0.0–0.1) | 0.1 (0.0–0.1) |
HPV71 | 5 | 0.0 (0.0–0.1) | 1 | 0.0 (0.0–0.0) | 2 | 0.0 (0.0–0.0) | 0.1 (0.0–0.1) |